Pilet C, Le Garrec Y
Dev Biol Stand. 1976;31:61, 399-407.
Within the framework of a study on the immunostimulant properties of Brucella abortus and of its extracts, we have investigated the protective activity on infection of mice by Klebsiella pneumoniae and on Charlotte Friend's leukemia, of inactivated Brucella abortus and brucella lysates by ultrasound. The injection of inactivated B 19 R preparations and their lysates three days before infection by klebsiella has allowed to protect mice against a large number of DL50 (100 and 1000 in certain cases). To determine the role of the surface antigen in this type of immunostimulant, the activity of the B 19 R inactivated preparations has also been examined. It appears that the protection obtained by the injection on day J + 3, in relation to the infection, does not depend on the presence of the complete surface antigen, while the long term effect seems to be more dependent on this. The development of Charlotte Friend's leukemia has been favourably influenced by the previous injection of B 19 S or inactivated B 19 R. Immunotherapy on days J + 1 or J + 3 gave encouraging results with B 19 R, but facilitation with B 19 S. These results confirm the immunostimulant activity of brucella which has already been reported by ourselves and by other authors.
在一项关于流产布鲁氏菌及其提取物免疫刺激特性的研究框架内,我们研究了经超声处理的灭活流产布鲁氏菌和布鲁氏菌裂解物对小鼠肺炎克雷伯菌感染及对夏洛特氏 Friend 白血病的保护活性。在感染肺炎克雷伯菌前三天注射灭活的 B19R 制剂及其裂解物,可使小鼠抵御大量半数致死剂量(某些情况下为 100 和 1000)。为确定表面抗原在这类免疫刺激剂中的作用,还检测了灭活的 B19R 制剂的活性。结果显示,在感染相关的 J + 3 天注射所获得的保护并不依赖于完整表面抗原的存在,而长期效果似乎更依赖于此。先前注射 B19S 或灭活的 B19R 对夏洛特氏 Friend 白血病的发展产生了有利影响。在 J + 1 天或 J + 3 天用 B19R 进行免疫治疗取得了令人鼓舞的结果,而用 B19S 则有促进作用。这些结果证实了我们自己以及其他作者已报道过的布鲁氏菌的免疫刺激活性。